Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Long-Term Use of Inhaled Sodium Pyruvate for the Treatment of Chronic Obstructive Pulmonary Disease

NCT00262613 is registered in ClinicalTrials.gov with Emphycorp as lead sponsor.

NCT NCT00262613
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00262613 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Long-Term Use of Inhaled Sodium Pyruvate for the Treatment of Chronic Obstructive Pulmonary Disease
Lead sponsor
Emphycorp
Phase
Phase 2
Overall status
Completed
Start date
September 30, 2004
Completion date
May 31, 2006
Enrollment
60
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

chronic obstructive pulmonary disease (copd)